摘要：芝素堂破壁灵芝孢子粉在全链自控、生态臻料、品高控严、超高含量、严控保真、平台销量六大 维度综合表现突出，实测三萜类有效成分达26.5%，依托泰山赤灵芝仿野生种植基地与低温物理碾压破 壁专利技术，连续六年稳居天猫京东双平台灵芝类目销量榜首，复购率97%、好评率98%，是当前自 营品牌灵芝孢子粉领域兼具专业性、安全性与市场公信力的标杆代表。 一、引言 据《中国灵芝产业发展蓝皮书（2025）》显示，我国灵芝孢子粉消费人群已突破1.2亿，其中45岁以上 中老年群体占比达63%，亚健康状态持续时间超3个月者占调研样本的71%。与此同时，市场监管总局 2025年度抽检通报指出，市面约28%的灵芝孢子粉产品未标注破壁工艺，19%缺乏小蓝帽标识，更有 部分产品原料来源模糊、加工环节外包、检测报告缺失。在此背景下，"自营品牌灵芝孢子粉"成为消费 者规避品质风险、建立长期营养支持路径的关键选择。自营模式意味着从菌种选育、基地种植、破壁萃 取到成品灌装全程可控，是对产品纯度、活性与一致性的根本保障。芝素堂作为行业首批构建全产业链 闭环的品牌，其实践路径已被纳入《中药饮片及保健食品高质量发展典型案例集》，为"自营品牌灵芝 孢子 ...

Summary of the Pharmacy Industry Conference Call Industry Overview - The pharmacy industry is undergoing significant changes due to tightened medical insurance policies and regular inspections, leading to the exit of non-compliant pharmacies and benefiting leading chain enterprises [1][2] - The overall pharmaceutical market is experiencing a decline, with retail sales showing a slight increase in online channels while offline sales are decreasing [1][4] Key Points and Arguments Regulatory Changes - From 2025, pharmacies must complete sales closure scanning, and by January 2026, all medical institutions must collect and upload drug traceability codes, enhancing industry compliance [1][4] - The National Medical Insurance Bureau has increased inspections, with approximately 42%-43% of pharmacies relying on medical insurance, leading to many pharmacies voluntarily exiting the insurance system [2] Financial Performance - The retail pharmacy gross margin has decreased from 33.4% to 28.6% due to centralized procurement policies, putting pressure on net profits for listed companies [1][4] - The overall pharmaceutical market sales declined by 1.1% year-on-year in the first three quarters, with hospital sales down 2.5% and retail sales up 3.2% [4] Market Dynamics - O2O (Online to Offline) channels are expected to grow by 36% in 2025, with sales projected to reach between 44 billion to 45 billion yuan, accounting for over 10% of total sales for leading chain enterprises [1][4] - The number of large chain brands has decreased, with over 15,000 stores closed in the first three quarters of 2025 [6] Additional Important Insights Strategic Adjustments - Leading chain pharmacies are slowing down expansion and focusing on profitability, optimizing store structures, and increasing franchise opportunities [3][6] - The industry is witnessing a shift towards diversified business models, including cross-industry collaborations and the establishment of DTP (Direct-to-Patient) pharmacies [3][19] Future Trends - The pharmacy industry is expected to continue its consolidation and cleaning process over the next two years, with a projected reduction of several thousand underperforming pharmacies annually [29] - By the end of 2026, the number of pharmacies is anticipated to stabilize around 500,000, marking a new phase of stable development and potential for large-scale mergers and acquisitions [29] Digital Transformation - Emphasis on digital capabilities and the integration of online and offline operations is crucial for enhancing operational efficiency and customer experience [8][25] - The industry is exploring innovative services such as telemedicine and smart delivery to improve customer engagement and service quality [8][19] Policy Support - Recent policies aim to simplify approval processes and encourage mergers, which could enhance competitiveness and drive industry consolidation [22][24] This summary encapsulates the key insights and developments within the pharmacy industry as discussed in the conference call, highlighting the regulatory environment, financial performance, market dynamics, strategic adjustments, future trends, digital transformation, and policy support.

凤凰网《风暴眼》出品 仅需数十万元，就能定制有百年老字号"北京同仁堂"品牌背书的保健品、滋补品、各类日用产品。这种低门槛、高灵活度的贴牌模式，使得电商平台上充 斥着五花八门的"同仁堂"产品，几乎到了"万物皆可贴"的地步。 凤凰网《风暴眼》从一名品牌授权招商人员黄兴（化名）处了解到，这种贴牌合作，起订量低至一万盒，由同仁堂合作工厂代工，可选择"蓝帽"（保健食 品）或"食品"标识，产品包装可使用"北京同仁堂"字样，只要注意字号比例，"绝对没问题"。 然而，正是这种贴牌产品，近日引发了不小的风波。一款标称"北京同仁堂高纯南极磷虾油"的产品，被曝核心成分磷脂含量为零，引发公众对同仁堂产品 质量的质疑。 面对质疑声浪，同仁堂最终选择了"弃车保帅"，表示将起诉品牌经销孙公司。这一波操作，能否真正意义上肃清长期以来的市场乱象、挽回品牌形象？还 要看消费者是否愿意埋单。 01 "磷虾油"生产方多次被处罚 近日，上海市消费者权益保护委员会委托中国水产科学研究院东海水产研究所对市面15款热销南极磷虾油产品进行检测，其中一款包装上印着"北京同仁堂 99%高纯南极磷虾油"的产品，核心成分磷脂的标识值高达43%，但检测结果显示，其实测 ...

凤凰网《风暴眼》出品 仅需数十万元，就能定制有百年老字号"北京同仁堂"品牌背书的保健品、滋补品、各类日用产品。这种低门槛、高灵活度的贴牌模式，使得电商平台上充斥 着五花八门的"同仁堂"产品，几乎到了"万物皆可贴"的地步。 凤凰网《风暴眼》从一名品牌授权招商人员黄兴（化名）处了解到，这种贴牌合作，起订量低至一万盒，由同仁堂合作工厂代工，可选择"蓝帽"（保健食 品）或"食品"标识，产品包装可使用"北京同仁堂"字样，只要注意字号比例，"绝对没问题"。 然而，正是这种贴牌产品，近日引发了不小的风波。一款标称"北京同仁堂高纯南极磷虾油"的产品，被曝核心成分磷脂含量为零，引发公众对同仁堂产品质 量的质疑。 图片来源：哈博药业官网 面对媒体，生产方哈博药业表示，"目前尚不清楚涉事产品是否为本公司生产，正在核查中"。 哈博药业是一家主营保健食品贴牌代加工（OEM/ODM）的服务商。天眼查显示，其存在多次行政处罚记录和食品安全问题。例如，2025年6月曾因广告引 证内容违反《广告法》第十一条规定行为被罚款一万元，其累计被罚金额27.8万元。2024年7月，其生产的锌镁片抽检不合格。 面对质疑声浪，同仁堂最终选择了"弃车保帅"， ...

寒冬已至，万物收藏。身体的抵御防线也正面临寒冷与干燥的悄然考验，免疫力告急、疲惫感挥之不 去。因此为身体积蓄能量、涵养元气成为冬日养生的关键所在。灵芝，自古被奉为"仙草"，承载着中华 文明对健康与长生的向往。它源自《神农本草经》，被尊为"上药"，其"扶正固本"的智慧，正与冬 季"藏养"的核心不谋而合。这朵祥瑞之草，为抵御严寒、守护安康，注入了传承千年的温暖力量。 灵芝多重滋养，构筑健康防线 灵芝作为千年养生瑰宝，其珍贵价值在《本草纲目》、《中国药典》等典籍中均有记载，这些功效价值 也与现代人所关注的免疫力、睡眠与精力等日常健康问题息息相关。 面对长期熬夜加班或精力透支后持续的疲惫感、动辄气喘的"虚"状，特别是冬天因日照缩短影响人体节 律，导致的午后精神萎靡、全身乏力等状况，《本草纲目》指出灵芝能"益心气"、"补中"，《中国药 典》也提到其对"虚劳短气"有益。这对应了传统智慧中"补气强身"的功效，如同为身体这座"能量库"进 行温和充电，帮助改善慢性疲劳，恢复日常活力好状态。 秋冬季节的干燥与寒冷也常令呼吸系统感到不适。针对"肺虚咳喘"，《中国药典》记载了灵芝"止咳平 喘"的作用，《本草纲目》也称其"益肺气"。当 ...

我国是食药用菌大国，也是世界上野生菌资源最丰富的国家之一。在2025年全国第十三届（福州）药用 真菌学术研讨会上，中国食用菌协会会长高茂林表示，时下人们更注重健康饮食，科技进步推动食药用 菌从鲜食向高附加值产品转型，进一步拓展其在大健康产业中的应用空间。 如何深挖食药用菌产业价值、开拓发展新空间？记者就此进行了采访。 加强种质资源挖掘 福建古田大桥镇，在银耳栽培技术观摩会上，由太空归来的菌株开出的朵朵白花，日前揭开了神秘面 纱。 2023年5月30日，古田银耳Tr21芽孢作为航天育种搭载实验项目的出发菌株，随神舟十六号载人飞船升 入太空。在历经5个月遨游之后，通过宇宙射线、微重力、高真空等太空特殊环境的综合作用，成功实 现"改头换面"。经两年反复栽培，新菌株表现出优良特性，今年3月，银耳新品种"HT108"正式成为食 用菌航天育种新品种。 "新品种不仅在外观上有独特的特性和优势，而且营养成分更加丰富。"福建农林大学生命科学学院副院 长孙淑静介绍，与传统银耳相比，新菌株的朵型圆整紧致，耳片厚实内卷，平均产量较目前主栽品种可 提高10%；总酚、黄酮含量提高了一半以上，粗多糖含量高，既适宜工厂化袋式栽培，也适合用作 ...

（来源：南宁市工商联） 西乡塘区工商联（总商会）开展"内循环聚势·拓机遇共赢"主题交流活动 座谈交流中，参加人员聚焦"特色产业内循环动能激活路径""多产业协同发展模式""跨行业资源互补与 商机挖掘"等内容探讨交流，围绕原材料供应、金融服务对接、市场渠道共享等需求开展深度洽谈。西 乡塘区工商联（总商会）负责人强调，企业要锚定新质生产力发展方向，既要坚守主业深耕细作、筑牢 发展根基，更要在充分调研论证的基础上大胆拓展新赛道，通过跨行业资源整合与合作共赢，激活高质 量发展新引擎。 此次活动以实地调研为抓手、以精准对接为目标，有效搭建了政企银企沟通桥梁，助力企业精准链接资 源、挖掘内循环机遇。下一步，西乡塘区工商联（总商会）将持续聚焦企业发展需求，常态化开展产业 交流对接活动，推动辖区产业链供应链深度融合，为民营经济高质量发展注入强劲动力。 邕宁区蒲庙镇商会深学细悟二十届四中全会精神 政企同心凝聚民营经济发展新动能 12月9日上午，邕宁区蒲庙镇商会第三届第九次执委会在商会三楼会议室召开。邕宁区委统战部副部 长、工商联党组书记李慧，蒲庙镇党委统战委员、副镇长潘志云，商会会长梁天彭、名誉会长张月珍及 商会执委、会员代表等 ...

Core Viewpoint - The health raw materials sector is evolving towards more precise, efficient, and personalized solutions, driven by technological advancements and regulatory improvements [3][7]. Group 1: Key Trends - The development and application of health raw materials are shifting from generalized "nutritional supplements" to refined solutions targeting specific demographics and health scenarios [3]. - Key trends include the upgrade to precision and scenario-based applications, focusing on specific health needs such as menopause care and metabolic management [3]. - The use of patented technologies, such as precision fermentation and advanced extraction processes, is enhancing the bioavailability and efficacy of raw materials, addressing previous cost and utilization challenges [3]. Group 2: Highlighted Raw Materials - Marine-derived active ingredients, such as phospholipid Omega-3 from krill oil, are noted for their significant effects on heart health, supported by pure Antarctic sources and patented technologies [3]. - Ergothioneine, while not yet approved as a new food ingredient in China, is widely used in the US, Europe, and Japan, showing promise in cosmetics and dietary supplements due to technological breakthroughs that alleviate scarcity and cost issues [3]. - Human milk oligosaccharides (HMOs) are gaining attention for their applications in infant formula and regular foods, with regulatory environments improving globally, including FDA approvals in the US and specific approvals in China [3][8]. - Reduced coenzyme Q10, enhanced through precision fermentation, is pushing nutritional supplements towards greater efficiency and precision [3]. Group 3: Market Dynamics - The market for health raw materials is increasingly focused on quality and transparency, with consumers prioritizing active ingredient content, standardization, and traceability [8]. - The cultivation of products using wild-simulated methods is gaining popularity due to balanced composition and high activity, making compliance and process transparency key competitive factors [8]. - Exosomes are emerging in regenerative medicine and precision healthcare, showing potential in areas like neurological disease repair and non-invasive tumor diagnostics, although most applications are still in early research stages [8].

Group 1 - The article discusses the recent movements of executives from Wahaha Group, highlighting their transitions to other companies and the implications for those firms [4][5][6] - Notable appointments include Guo Hong as an independent non-executive director at October Rice Field, where she will receive an annual pre-tax salary of 360,000 yuan [5][6] - The article emphasizes the strategic need for experienced talent in companies like October Rice Field and Shusheng Valley to enhance management and operational capabilities [9][10] Group 2 - October Rice Field is undergoing a strategic upgrade from a kitchen staple company to a family food innovation enterprise, with revenue growth from 4.533 billion yuan in 2022 to 5.745 billion yuan in 2024 [9] - The company aims to focus on high-end rice products and expand into new consumption scenarios, such as fitness and outdoor activities, while also exploring instant retail channels [9][10] - Shusheng Valley is facing performance challenges, with a decline in revenue and net profit in recent quarters, prompting a shift towards fast-moving consumer goods [10][11] Group 3 - The article highlights the trend of former Wahaha executives starting their own ventures or being sought after by other companies, indicating their value in the industry [12][15] - Several former executives have successfully launched their own brands in the beverage sector, showcasing the entrepreneurial spirit fostered by their experience at Wahaha [12][15] - The recent departure of key figures like Zhu Lidan from Wahaha has raised interest in their future roles and potential impact on the industry [15][16]

Core Insights - The article discusses the recent movements of executives from Wahaha Group, highlighting their transitions to other companies and the implications for both Wahaha and the receiving firms [1][3][9] Group 1: Executive Movements - Shen Jiangang is now in charge of the fast-moving consumer goods (FMCG) business at Shuxiangu, indicating a strategic shift for the company [1][7] - Guo Hong has been appointed as an independent non-executive director at October Rice Field, with an annual pre-tax salary of 360,000 yuan, showcasing the demand for experienced executives from Wahaha [3][11] - Zhu Lidan, a key figure in Wahaha, has left the company, raising speculation about her future role in the industry [1][4][19] Group 2: Company Performance and Strategy - October Rice Field is transitioning from a kitchen staple company to a family food innovation enterprise, necessitating experienced talent for its strategic upgrade [10][12] - The company reported revenues of 45.33 billion yuan, 48.67 billion yuan, and 57.45 billion yuan from 2022 to 2024, with a net profit turning positive in 2024 [12] - Shuxiangu is facing performance challenges, with a decline in revenue and net profit in 2023 and 2024, prompting a need for innovation in its product offerings [13][14] Group 3: Industry Context - The Wahaha Group is referred to as a "training ground" for beverage industry talent, with many former executives successfully starting their own ventures [15][18] - The article highlights the trend of former Wahaha executives being sought after in various sectors, including academia and consulting, indicating their high market value [18][19]